Elanco Animal Health Lawsuit: Investors with Losses Exceeding $100,000 Encouraged to Contact Faruqi & Faruqi
Faruqi & Faruqi, LLP, a leading national securities law firm, is actively investigating potential legal claims against Elanco Animal Health Incorporated (ELAN). The firm is representing investors who may have suffered significant financial losses due to alleged misstatements and omissions by Elanco concerning its new products, Zenrelia and Credelio Quattro.
What is the Allegation?
The lawsuit alleges that Elanco, a company specializing in animal health products, misled investors about the safety and commercial launch timelines of Zenrelia and Credelio Quattro. Specifically, the complaint alleges that Elanco:
*
Downplayed the safety concerns of Zenrelia:
The lawsuit claims that Elanco presented Zenrelia as safer than it actually was, failing to adequately disclose potential risks.*
Misrepresented the launch timeline:
The complaint alleges that Elanco made false statements regarding the expected approval and launch dates for both Zenrelia and Credelio Quattro in the U.S. market, ultimately causing investor expectations to be inflated.*
Overstated the company’s financial prospects:
The lawsuit asserts that Elanco’s optimistic projections about its business were based on misleading information about the safety and launch of its new products.The Impact on Elanco’s Stock Price
On June 27, 2024, Elanco issued a press release acknowledging the safety concerns surrounding Zenrelia and revising the anticipated launch timelines for both products. This news led to a significant drop in Elanco’s stock price, plummeting 20.59% on that day.
Who Should Contact Faruqi & Faruqi?
If you are an investor who:
* Purchased Elanco securities between November 7, 2023, and June 26, 2024, and
* Suffered losses exceeding $100,000,
You are encouraged to contact Faruqi & Faruqi directly. The firm offers a free consultation to discuss your legal options.
How to Get Involved
Investors who meet the above criteria have the option to participate in the federal securities class action lawsuit against Elanco. The deadline to seek the role of lead plaintiff in the lawsuit is December 6, 2024. The lead plaintiff will represent the interests of all members of the class in the litigation.
Contact Information
To learn more about the lawsuit and your potential rights as an investor, please contact:
*
James (Josh) Wilson, Partner:
877-247-4292 or 212-983-9330 (Ext. 1310)*
Email:
jwilson@faruqilaw.com*
Website:
www.faruqilaw.com/ELANAbout Faruqi & Faruqi, LLP
Faruqi & Faruqi, LLP is a nationally recognized law firm with offices in New York, Pennsylvania, California, and Georgia. The firm specializes in securities litigation and has recovered hundreds of millions of dollars for investors since its founding in 1995.